Research study Program year 2022 Source: CMS Open Payments

Ux023-Cl401

Research payments

$4,989,325

352 payments

Through program year 2022, $4,989,325 in research payments was reported against Ux023-Cl401, across 352 payments, paid by Ultragenyx Pharmaceutical Inc..

Paid by
Ultragenyx Pharmaceutical Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

4 rows
Year Kind Amount Payments
2022 Research $1,987,382 140
2021 Research $723,008 22
2020 Research $1,195,842 101
2019 Research $1,083,094 89

Breakdown

Who paid Research payments · program years 2019–2022
  1. Ultragenyx Pharmaceutical Inc. $4,989,325 352 payments
Who received the money Research payments · program years 2019–2022
  1. Yale University School Of Medicine Organisation paid for research $970,565 11 payments
  2. Vanderbilt University Medical Center Teaching hospital · TN $697,216 36 payments
  3. Indiana University Organisation paid for research $351,592 14 payments
  4. Johns Hopkins University Organisation paid for research $331,651 41 payments
  5. Yale University Organisation paid for research $303,673 15 payments
  6. Childrens Hospital Los Angeles Teaching hospital · CA $275,849 13 payments
  7. Langley Porter Psychiatric Hospital Teaching hospital · CA $241,411 10 payments
  8. Childrens Hospital Colorado Teaching hospital · CO $231,570 12 payments
  9. Indiana University Financial Management Services Organisation paid for research $193,610 8 payments
  10. Duke University Medical Center Organisation paid for research $150,207 9 payments

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program years 2019–2022
  1. Patient care $1,182,852 96 payments
  2. Other $1,083,094 89 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record